Taiwo Emiola, ARNP - Medicare Nurse Practitioner in Brandon, FL

Taiwo Emiola, ARNP is a medicare enrolled "Clinical Nurse Specialist - Family Health" in Brandon, Florida. She graduated from nursing school in 2016 and has 8 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice Baycare Behavioral Health Inc, Behavioral Health Management Services, Inc and her current practice location is 106 W Windhorst Rd Fl 33510, Brandon, Florida. You can reach out to her office (for appointments etc.) via phone at (813) 373-9531.

Taiwo Emiola is licensed to practice in Florida (license number 9321412) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1740729334.

Contact Information

Taiwo Emiola, ARNP
106 W Windhorst Rd Fl 33510,
Brandon, FL 33510-2455
(813) 373-9531
Not Available



Provider's Profile

Full NameTaiwo Emiola
GenderFemale
SpecialityNurse Practitioner
Experience8 Years
Location106 W Windhorst Rd Fl 33510, Brandon, Florida
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Taiwo Emiola graduated from nursing school in 2016
  NPI Data:
  • NPI Number: 1740729334
  • Provider Enumeration Date: 02/16/2017
  • Last Update Date: 11/29/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 9234543117
  • Enrollment ID: I20210204001858

Medical Identifiers

Medical identifiers for Taiwo Emiola such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1740729334NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
364SF0001XClinical Nurse Specialist - Family Health 9321412 (Florida)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Baycare Behavioral Health Inc468864912237
Behavioral Health Management Services, Inc145626245016

News Archive

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Taiwo Emiola allows following entities to bill medicare on her behalf.
Entity NameBehavioral Health Management Services, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1417052713
PECOS PAC ID: 1456262450
Enrollment ID: O20040115000480

News Archive

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

Read more Medical News

› Verified 4 days ago

Entity NameWinter Haven Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477599975
PECOS PAC ID: 4789578972
Enrollment ID: O20040210000095

News Archive

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

Read more Medical News

› Verified 4 days ago

Entity NameBaycare Behavioral Health Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1225312549
PECOS PAC ID: 4688649122
Enrollment ID: O20040830000131

News Archive

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

Read more Medical News

› Verified 4 days ago

Entity NameBaycare Behavioral Health Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245502152
PECOS PAC ID: 2567624836
Enrollment ID: O20120502000477

News Archive

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

Read more Medical News

› Verified 4 days ago

Entity NameGrow Healthcare Group Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245845932
PECOS PAC ID: 3476961368
Enrollment ID: O20210414000053

News Archive

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Taiwo Emiola is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Taiwo Emiola, ARNP
8002 King Helie Blvd,
New Port Richey, FL 34653-1435

Ph: (727) 841-4200
Taiwo Emiola, ARNP
106 W Windhorst Rd Fl 33510,
Brandon, FL 33510-2455

Ph: (813) 373-9531

News Archive

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Stago receives FDA approval for automated, highly sensitive D-dimer test

Stago has received approval from the US Food and Drug Administration for the reagent STA -Liatest D-Di, in the exclusion of pulmonary embolism (PE) in patients with low or moderate risk, presenting at an emergency unit.

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

Serum aldosterone concentrations provide a new measure for risk evaluation in HFpEF patients

Currently, patients with HFpEF have high risk of morbidity and mortality, but there is no effective measure for evaluating the prognosis.

Read more News

› Verified 4 days ago


Clinical Nurse Specialist Nurses in Brandon, FL

Kathyleen Volpe Hedrick, MS ARNP
Clinical Nurse Specialist
Medicare: Not Enrolled in Medicare
Practice Location: 500 Vonderburg Drive, Ste 115w, Brandon, FL 33511
Phone: 813-685-0306    Fax: 813-651-1026
Maribel Nancy Luna,
Clinical Nurse Specialist
Medicare: Not Enrolled in Medicare
Practice Location: 608 Pinewalk Dr, Brandon, FL 33510
Phone: 813-610-4177    
Darlyne Georges,
Clinical Nurse Specialist
Medicare: Medicare Enrolled
Practice Location: 214 W Brandon Blvd, Brandon, FL 33511
Phone: 813-438-5220    Fax: 813-438-5220

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.